tirzepatide bodybuilding Ozempic bodybuilders push for open access to weight loss drug Tirzepatide vs Semaglutide: Weight Loss

What the clinical trial evidence shows Mounjaro (tirzepatide) ~22.5% average body weight lost at 72 weeks ( SURMOUNT-1, 15mg) Wegovy (semaglutide) ~14.9% average body weight lost at 68 weeks ( STEP-1 , 2.4mg) Saxenda / Nevolat (liraglutide) ~5-8% average body weight lost at 56 weeks ( SCALE trial ) For context, prior to GLP-1 medications, the most effective non-surgical weight loss intervention available was a combination of intensive lifestyle modification and Orlistat , which typically produces 5 to 8% weight loss

Specific advice for the menopause stage of life and beyond

Glucagon-like peptide-1 (GLP-1)-based therapeutics: current status and future opportunities beyond type 2 diabetes

Henry Sobo, MD Peptide Therapy, Medical Weight Loss, Connecticut Peptide therapy works best when the treatment plan is personalized, medically supervised, and followed consistently

One key factor is the C rating, which defines how fast a battery can charge or discharge safely

Ferroptosis, a new target for treatment of renal injury and fibrosis in a 5/6 nephrectomy-induced CKD rat model